IL98725A - 3 -]) 5-Methyl-2-furanyl (methyl (-N-) 4-piperidinyl (-H3-imidazo] B-4,5 [pyridine-2-amine 2-hydroxy-1,2,3-propanthric - Google Patents

3 -]) 5-Methyl-2-furanyl (methyl (-N-) 4-piperidinyl (-H3-imidazo] B-4,5 [pyridine-2-amine 2-hydroxy-1,2,3-propanthric

Info

Publication number
IL98725A
IL98725A IL9872591A IL9872591A IL98725A IL 98725 A IL98725 A IL 98725A IL 9872591 A IL9872591 A IL 9872591A IL 9872591 A IL9872591 A IL 9872591A IL 98725 A IL98725 A IL 98725A
Authority
IL
Israel
Prior art keywords
noberastine
citrate
methyl
solution
noberastine citrate
Prior art date
Application number
IL9872591A
Other languages
English (en)
Hebrew (he)
Other versions
IL98725A0 (en
Inventor
Alfons Gaston Maria De Knaep
Tonny Franciscus Johanna Nelen
Frans Eduard Janssens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL98725A0 publication Critical patent/IL98725A0/xx
Publication of IL98725A publication Critical patent/IL98725A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
IL9872591A 1990-07-06 1991-07-04 3 -]) 5-Methyl-2-furanyl (methyl (-N-) 4-piperidinyl (-H3-imidazo] B-4,5 [pyridine-2-amine 2-hydroxy-1,2,3-propanthric IL98725A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54935090A 1990-07-06 1990-07-06

Publications (2)

Publication Number Publication Date
IL98725A0 IL98725A0 (en) 1992-07-15
IL98725A true IL98725A (en) 1995-07-31

Family

ID=24192647

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9872591A IL98725A (en) 1990-07-06 1991-07-04 3 -]) 5-Methyl-2-furanyl (methyl (-N-) 4-piperidinyl (-H3-imidazo] B-4,5 [pyridine-2-amine 2-hydroxy-1,2,3-propanthric

Country Status (25)

Country Link
EP (1) EP0464927B1 (fr)
JP (1) JPH04230382A (fr)
KR (1) KR0165894B1 (fr)
CN (1) CN1026790C (fr)
AT (1) ATE142207T1 (fr)
AU (1) AU632949B2 (fr)
BG (1) BG60067A3 (fr)
CA (1) CA2043564A1 (fr)
CZ (1) CZ279435B6 (fr)
DE (1) DE69121807T2 (fr)
ES (1) ES2091285T3 (fr)
FI (1) FI94132C (fr)
GR (1) GR3020951T3 (fr)
HU (1) HUT58333A (fr)
IE (1) IE75695B1 (fr)
IL (1) IL98725A (fr)
MX (1) MX9100102A (fr)
NO (1) NO177854C (fr)
NZ (1) NZ238369A (fr)
PL (1) PL168719B1 (fr)
PT (1) PT98215B (fr)
RU (1) RU2047615C1 (fr)
SG (1) SG48825A1 (fr)
SK (1) SK278127B6 (fr)
ZA (1) ZA915241B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
KR100289063B1 (ko) * 1997-12-17 2001-05-02 정선종 누름스윗치에의한휴대전화기용자동안테나

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
EP0232937B1 (fr) * 1986-02-03 1992-08-19 Janssen Pharmaceutica N.V. Compositions anti-histaminiques contenant des N-hétérocyclyl-4-pipéridinamines
GB8900380D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives

Also Published As

Publication number Publication date
SK278127B6 (en) 1996-02-07
NO912650D0 (no) 1991-07-05
NO177854B (no) 1995-08-28
CN1026790C (zh) 1994-11-30
IE912362A1 (en) 1992-01-15
HU912284D0 (en) 1991-12-30
ATE142207T1 (de) 1996-09-15
GR3020951T3 (en) 1996-12-31
CZ279435B6 (cs) 1995-04-12
HUT58333A (en) 1992-02-28
RU2047615C1 (ru) 1995-11-10
DE69121807T2 (de) 1997-01-23
IL98725A0 (en) 1992-07-15
NZ238369A (en) 1993-07-27
CS198791A3 (en) 1992-03-18
EP0464927A3 (en) 1992-04-08
CN1058020A (zh) 1992-01-22
PL168719B1 (pl) 1996-03-29
NO177854C (no) 1995-12-06
PT98215A (pt) 1992-06-30
KR0165894B1 (ko) 1999-01-15
FI913281A0 (fi) 1991-07-05
MX9100102A (es) 1992-02-28
JPH04230382A (ja) 1992-08-19
FI94132B (fi) 1995-04-13
AU8020691A (en) 1992-01-09
DE69121807D1 (de) 1996-10-10
ZA915241B (en) 1993-03-31
CA2043564A1 (fr) 1992-01-07
FI94132C (fi) 1995-07-25
ES2091285T3 (es) 1996-11-01
BG60067A3 (en) 1993-09-15
EP0464927B1 (fr) 1996-09-04
SG48825A1 (en) 1998-05-18
IE75695B1 (en) 1997-09-10
PL290956A1 (en) 1992-06-26
AU632949B2 (en) 1993-01-14
EP0464927A2 (fr) 1992-01-08
FI913281A (fi) 1992-01-07
PT98215B (pt) 1999-01-29
KR920002597A (ko) 1992-02-28
NO912650L (no) 1992-01-07

Similar Documents

Publication Publication Date Title
EP0304019B1 (fr) Acide cristallin 3-céphem-4 carboxylique 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacétamido)-3-vinyle (isomère syn)
EP0340677B1 (fr) Monohydrate de gabapentin et un procédé pour sa préparation
EP2504334B1 (fr) Procédé de purification du methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate
RU2323214C2 (ru) Способы получения производных 1-[2-(бензимидазол-1-ил)хинолин-8-ил]пиперидин-4-иламина
EP2607363B1 (fr) Composé cyclique fusionné utilisé comme antagoniste des récepteurs des minéralocorticoïdes
SI9300287A (en) Process for preparing aryl piperazinyl-heterocyclic compounds
EP0258755A1 (fr) Alpha-alkyl-4-amino-3-quinoléine-méthanols et 1-(4-aralkylamino-3-quinolyl)alkanones, un procédé pour leur synthèse et leur utilisation comme médicaments
RU2125571C1 (ru) СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
JP2017014270A (ja) 光学活性ピペリジン誘導体の酸付加塩及びその製法
US5354760A (en) Crystalline Tiagabine monohydrate, its preparation and use
CA3203447A1 (fr) Serie de composes d'acide benzoique substitues par piperidine et leur utilisation
US5403931A (en) (-)-(S)-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane L-tartrate
LV10868B (en) Oxadiazolyl-alkyl-purine derivatives
CN114746149A (zh) 作为肝脏x受体激动剂的1,2,4-噁二唑衍生物
AU632949B2 (en) 3-{(5-methyl-2-furanyl)methyl}-n-(4-piperidinyl)-3 h-imidazo {4,5-b}-pyridin-2-amine 2-hydroxy-1, 2,3-propanetricarboxylate
EP0440642B1 (fr) Hydrohalogenures de rifapentine
EP3707141B1 (fr) 2,4-dihydro-3h-1,2,4-triazol-3-ones substituées et leur utilisation
CZ21598A3 (cs) Způsob přípravy izolované krystalické formy 3/2 hydrátu 7-[(7-(S)-amino-5-azaspirol[2,4]heptal-5-yl]-8-chlor-6-fluor-1-[(1R,2S)-2-fluorcyklopropyl]-4-oxo-1,4-dihydrochinolin-3-karboxylové kyseliny
US4264602A (en) 4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones
US3024242A (en) 3-amino-nu-nitro-2-oxo-1-piperidine-carboxamidine
EP0367944A2 (fr) Dérivés éthérés de 4-[3H]-quinazolinone, procédé pour leur préparation et compositions pharmaceutiques
JPH069642A (ja) ４−デソキシ−４−エピポドフィロトキシン誘導体及びその塩
US4010265A (en) 8-Alkylpyrido[3,4-d]pyridazines
EP0182271B1 (fr) Dérivés dibromo Nb-quaternaires d'ajmaline, isoajmaline, sandwicine et isosandwicine et compositions pharmaceutiques contenant ces dérivés, produits intermédiaires et procédé pour leur préparation
CA2444897A1 (fr) Sulfate d'un compose cepheme

Legal Events

Date Code Title Description
KB Patent renewed